Baiyunshan Hutchison Whampoa Chinese Medicine Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 1,234

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Baiyunshan Hutchison Whampoa Chinese Medicine General Information

Description

Manufacturer of traditional Chinese medicines and herbal pharmaceutical products aims to modernize and globalize classical TCM formulations. The company's offerings feature proprietary herbal remedies, GMP-certified manufacturing lines, integration of traditional formulas with modern quality control systems, and strategic heritage brands like Banlangen granules and Niuhuang Jiedu tablets, helping customers access standardized, safe, and effective Chinese medicines, enabling broader adoption of TCM in both domestic and international healthcare markets.

Contact Information

Website
www.813zy.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Guangzhou, Guangdong
  • China
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Guangzhou, Guangdong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baiyunshan Hutchison Whampoa Chinese Medicine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baiyunshan Hutchison Whampoa Chinese Medicine‘s full profile, request access.

Request a free trial

Baiyunshan Hutchison Whampoa Chinese Medicine Patents

Baiyunshan Hutchison Whampoa Chinese Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024255011-A1 New use of compound salvia miltiorrhiza preparation Inactive 14-Jun-2023
AU-2020103237-A4 Application of rabdosia serra in preventing or treating alcohol dependence Active 03-Sep-2020
AU-2021103200-A4 Application of rabdosia serra in preventing or treating nicotine dependence Active 03-Sep-2020
AU-2021101213-A4 Rabdosia serra composition and its application Active 03-Sep-2020
AU-2018101247-A4 Application of persimmon leaf extract in the preparation of medicines for the treatment of primary insomnia Inactive 12-Dec-2017 A61K36/44
To view Baiyunshan Hutchison Whampoa Chinese Medicine’s complete patent history, request access »

Baiyunshan Hutchison Whampoa Chinese Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baiyunshan Hutchison Whampoa Chinese Medicine Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baiyunshan Hutchison Whampoa Chinese Medicine‘s full profile, request access.

Request a free trial

Baiyunshan Hutchison Whampoa Chinese Medicine FAQs

  • When was Baiyunshan Hutchison Whampoa Chinese Medicine founded?

    Baiyunshan Hutchison Whampoa Chinese Medicine was founded in 2005.

  • Where is Baiyunshan Hutchison Whampoa Chinese Medicine headquartered?

    Baiyunshan Hutchison Whampoa Chinese Medicine is headquartered in Guangzhou, China.

  • What is the size of Baiyunshan Hutchison Whampoa Chinese Medicine?

    Baiyunshan Hutchison Whampoa Chinese Medicine has 1,234 total employees.

  • What industry is Baiyunshan Hutchison Whampoa Chinese Medicine in?

    Baiyunshan Hutchison Whampoa Chinese Medicine’s primary industry is Pharmaceuticals.

  • Is Baiyunshan Hutchison Whampoa Chinese Medicine a private or public company?

    Baiyunshan Hutchison Whampoa Chinese Medicine is a Private company.

  • What is the current valuation of Baiyunshan Hutchison Whampoa Chinese Medicine?

    The current valuation of Baiyunshan Hutchison Whampoa Chinese Medicine is .

  • What is Baiyunshan Hutchison Whampoa Chinese Medicine’s current revenue?

    The current revenue for Baiyunshan Hutchison Whampoa Chinese Medicine is .

  • Who are Baiyunshan Hutchison Whampoa Chinese Medicine’s investors?

    GL Capital Group and Guangzhou Baiyunshan have invested in Baiyunshan Hutchison Whampoa Chinese Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process